SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-297984
Filing Date
2022-12-05
Accepted
2022-12-05 07:09:09
Documents
15
Period of Report
2022-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418526d8k.htm   iXBRL 8-K 38704
2 EX-10.1 d418526dex101.htm EX-10.1 1046914
3 EX-99.1 d418526dex991.htm EX-99.1 10436
7 GRAPHIC g418526g1203083436072.jpg GRAPHIC 4322
  Complete submission text file 0001193125-22-297984.txt   1467228

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lnth-20221202.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20221202_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20221202_pre.xml EX-101.PRE 10814
9 EXTRACTED XBRL INSTANCE DOCUMENT d418526d8k_htm.xml XML 3235
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 221443735
SIC: 2835 In Vitro & In Vivo Diagnostic Substances